Immunohistochemistry
Principles and its application in
diagnosis
Presented by : Jaandeep Singh
Introduction
Immunohistochemistry is a technique for identifying cellular or tissue
constituents by means of antigen-antibody interactions. The site of antibody
binding to a particular antigenic determinant ie a epitope could be either direct
labelling of the antibody or by the use of secondary labelling method.
Principle
The primary or the secondary antibody that
shall bind to the epitope through vanderwall
forces is conjugated with a enzyme such as
horseradish peroxidase or a fluorescent label
such as fluoroscein thoicynate(FITC).
After binding to the specific antigen that shall be
located anywhere inside the cell or preferentially
present on a cell with a specific phenotype, the
label attaches to the antigen indirectly through
the primary or secondary antibody.
When a chromogen such as Diaminobenizdine
is added to the setup, the horseradish
peroxidase converts DAB into a brown
compound which stains the labelled antibody
and the associated antigen to which it was
bound and hence give a colour suitable for light
microscopy.
Obtaining a sample
• For IHC, sample could be either
obtained from a biopsy or a surgical
procedure. The most routine in
obtaining a sample is through Fine
Needle Aspiration(FNA).
• In this technique, a thin (23-25) gauge,
hollow needle is inserted into the mass
for sampling of cells.
• Fine needle aspiration biopsies are very
safe minor surgical procedures. Often
a major surgical biopsy can be avoided
by performing a needle aspiration
biopsy instead, eliminating the need
for hospitalisation.
Aspiration techniques
Suction FNAC Capillary method
• In this method, the needle is
passed into the lesion and
negative pressure is applied,
usually by virtue of a syringe
attached to the needle
• Used predominantly, also known
as the non aspiration technique
• The needle is passed into the
lesion and multiple fast jabbing
movements in and out of the
lesion as well as in different
directions are performed.
Immunohistochemistry Protocol
Fixation and processing
Section cutting
Deparafinisation and rehydration
Blocking endogenous enzyme
Blocking non specific antibody binding
Antigen retrieval
Primary antibody
Chromagen
Chromagen enhancement
Counter staining
Mounting
Fixation
The purpose of fixation is to preserve tissue so that it is resistant to undergoing further
changes, e.g. by the action of tissue enzymes or microorganisms.
Fixation of tissues is necessary:
a. To adequately preserve cellular components, including soluble and structural proteins.
b. To prevent autolysis and displacement of cell constituents, including Ags and enzymes.
c. To stabilize cellular materials against deleterious effects of subsequent procedures
d. To facilitate conventional staining and immunostaining.
However, the effects of fixation,
including protein-protein and
protein-nucleic acid cross linking and
calcium ion bonding, mask or damage
epitopes through alteration of the
protein 3 dimensional structure.
These changes can often be reversed
by any of the multiple antigen
retrieval methods.
Prevention of false positives
Sometimes normal and neoplasticism cells have endogenous enzyme activity
such as peroxidase or alkaline phosphatase. This leads to the generation of false
results as the chromogen specific as a substrate for the enzyme stains the
antigen when associated with a primary or secondary antibody, but also stains
the tissue under inspection diffusely due to the presence of endogenous enzymes.
To counteract this, endogenous enzymes need to be blocked before addition of the
conjugated Ab- chromogen complex. The most frequently used method is pre-
incubation of the sections in absolute methanol containing hydrogen peroxide.
A. Before blocking endogenous enzyme
activity
B. After blocking endogenous
enzyme activity
Antigen retrieval methods
Antigen retrieval refers to the unmasking of the epitopes which was induced by formalin
fixation and leads to the accessibility of the antigen.
The exact mechanism by which antigen retrieval works on formalin-fixed tissues is not
clear. A variety of pathways may contribute to its success, including the breaking of
cross-linkages, the extraction of diffusible blocking proteins, the precipitation of
proteins, the hydrolysis of Schiff's bases, calcium chelation, paraffin removal, and the
rehydration of tissue, resulting in better penetration of antibody and increased
accessibility to antigen
The two major ways through
which antigen retrieval is
carried out are
Protease induced antigen
retrieval(PIER)
Heat induced antigen
retrieval (HIER)
Several heating methods can be used to achieve the
AR results(HIER):
Water baths
Microwave ovens
Pressure cookers
Steamers
Antigen retrieval methods
Antibodies used in IHC assay
Polyclonal antibodies Monoclonal antibod
1. Purified immunogen is injected in mice
2. B lymphocytes are harvested f
3. B lymphocytes who have a limited lifespan are fused with ever dividing
non senescent myeloma cells to produce a hybridoma
The hybridomas having the desired specificity is
then selected. The hybrid cell produced is a
immortal cell that produces Igs specific for a single
epitope.(monoclonal antibodies)
Polyclonal antibodies are produced in multiple
animal species, particularly rabbit, horse,
goat and chicken. Polyclonal Abs have a
higher affinity and wide reactivity but lower
specificity when compared with monoclonal
Abs.
They are produced by immunizing an animal
with a purified specific molecule (immunogen)
bearing the antigen of interest. The animal
will mount a humoral response to the
immunogen and the antibodies so produced
can be harvested. It is likely that the animal
will produce multiple clones of plasma cells
and hence polyclonal Abs are obtained.
Labels
In immunohistochemistry, many labels can be used for visualization of an
antigen under light or dark microscopy when conjugated with primary or
secondary antibodies.
Enzyme labels
Most commonly used labels in immunohistochemistry due to their small size and prevention
of hinderance in binding of Abs to the adjacent sites.
The following are the major enzyme labels used in IHC:
• Horseradish peroxidase
• Glucose oxidase
• Alkaline phosphatase
• Beta D-galactosidase
Fluorescent labels
More commonly used in frozen sections.
Fluorophore linked antibodies emit a specific colour when excited by correct wavelengths of
light.
The benefit of using fluorophores is that they provide an easy method for performing double-
labelling experiments where several antibodies towards multiple targets are assayed in the
same sample. The secondary antibodies need to be targeted towards different primary
antibodies and also coupled to different fluorophores. The different secondary antibodies are
then observed separately by exciting them sequentially with different wavelengths. These
different excitation results are saved as separate images or colour channels and may later
be overlaid to infer protein co-localizations.
The various fluorochromes
commonly used are:
• Fluoroscein thiocynate(FITC)
• TRITC(rhodamine)
• Texas red
• R-phytoerythrin(PE)
Direct Labelling
Secondary labelling
• There is only one primary antibody that is
attached to the antigenic epitope which
could be cytoplasmic, membranous or
nuclear.
• Immunohistochemical staining methods
include use of fluorophore-labeled
(immunofluorescence) and enzyme-labeled
(immunoperoxidase) antibodies to identify
proteins and other molecules in cells
• In this method, the primary antibody
devoid of any fluorochrome or
immunoperoxidase activity binds to the
epitope of a protein.
• A secondary antibody binds to an
epitope on the initial primary antibody
and has associated with it some
labelling activity. This is also referred
to as the indirect method of
histochemical labelling.
Procedure at SMIH
• Deparafinization of tissue sections taken on polylysine coated slides
• Quenching endogenous peroxidase
• Antigen retrieval
• Serum incubation
• Binding of primary antibody
• Binding with enzyme labelled secondary antibody
• Addition of chromogen substrate DAB
• Counterstain, dehydrate coverslipping
• Interpretation of pattern of staining and integration of IHC in correct
clinical setting
Application of IHC in diagnostics and theranostics.
• IHC is a major tool in the armentarium of a pathologist to confirm or
differentiate between tumors
• Certain differentiation markers present in the cytoplasm, nucleus or
the cell membrane serve as epitopes for antibody labelling. These
markers are localised in certain cell lines such as epithelial,
mesenchymal, hematopoetic, neuroendocrine, melanocytes to name a
few. It is exciting to see that these markers can serve as strong
diagnostic tools and panels for differentiating between different
tumour phenotype.
Markers of differentiation
1. Cytokeratins
• Cytokeratins are the the most important markers
used for the diagnosis of epithelial neoplasms.
• Cytokeratins are intermediate filament proteins
building an intracytoplasmic network between the
nucleus and cell membrane of epithelial cells
• Cytokeratins are a complex family composed of
more than 20 isotypes and divided into two
groups which usually heterodimerize with each
other:
• Type I(acidic group) including cytokeratins 9-20
• Type II(basic group) including cytokeratins 1-8
Keratins are also divided into high molecular weight
keratins(HMWK) and low molecular weight
keratins(LMWK)
Major classes of keratins
CK8/18= simple one layered non polar
epithelial cells
Gastrointestinal epithelium additionally
expresses CK19
Goblet cells and mature enterocytes: CK20
Biliary,pancreatic ducts, renal collecting
tubules: CK7(and transitional epithelium)
Basal layer: CK5/14
Intermediate and superficial layers:
1. Non cornified: 4/13
2. Cornified: 1/10
Transitional epithelium- additional CK20 expression along with 8,18,19,7
Mesothelium- CK8,18,19,7(simple epithelia) and stratified epithelial CK5,14
1) HMWK- expressed in squamous cell carcinomas
2) LMWK- expressed in glandular epithelium and visceral parenchyma
Simple epithelium
Stratified epithelium
2. Epithelial membrane antigen: LMWK equivalent(marker of glandular
epithelium)
3. Carcinoembryonic antigen: marker of glandular epithelium
4. p63: HMWK equivalent: squamous and urothelial epithelium
5. Vimentin: vimentin is a 57kDa protein, a member of the Type III family of
intermediate filaments, expressed in all mesenchymal cells forming an
important part of the cytoskeleton of these cells.
6. S100 protein: structurally similar to calmodulin however differ from it
in terms of cell specific expression pattern. S100 proteins are involved in
regulation of protein phosphorylation, transcription factors, Ca++
homeostasis, the dynamics of cytoskeleton constituents, cell growth and
differentiation.
It can be found in 100% of melanomas and schwannomas.
7. CD45/leukocyte common antigen: family of high molecular mass integral
membrane glycoprotein molecules expressed on all hematopoietic cells
except mature red cells and their immediate progenitors,
megakaryocytes, and platelets.
Specific marker for lymphatic and hemopoetic tumours.
Carcinoma Sarcoma Melanoma Lymphoma
Keratins + - - -
S100 -/+ - + -
LCA - - - +
Vimentin - + + +
Diagnosis of Tumours based on IHC
Further reading
1. Rubin’s pathology
2. Immunohistochemistry in tumour diagnostics- Tuffaha-Guski-Kristiansen

Immunohistochemistry

  • 1.
    Immunohistochemistry Principles and itsapplication in diagnosis Presented by : Jaandeep Singh
  • 2.
    Introduction Immunohistochemistry is atechnique for identifying cellular or tissue constituents by means of antigen-antibody interactions. The site of antibody binding to a particular antigenic determinant ie a epitope could be either direct labelling of the antibody or by the use of secondary labelling method.
  • 3.
    Principle The primary orthe secondary antibody that shall bind to the epitope through vanderwall forces is conjugated with a enzyme such as horseradish peroxidase or a fluorescent label such as fluoroscein thoicynate(FITC). After binding to the specific antigen that shall be located anywhere inside the cell or preferentially present on a cell with a specific phenotype, the label attaches to the antigen indirectly through the primary or secondary antibody. When a chromogen such as Diaminobenizdine is added to the setup, the horseradish peroxidase converts DAB into a brown compound which stains the labelled antibody and the associated antigen to which it was bound and hence give a colour suitable for light microscopy.
  • 4.
    Obtaining a sample •For IHC, sample could be either obtained from a biopsy or a surgical procedure. The most routine in obtaining a sample is through Fine Needle Aspiration(FNA). • In this technique, a thin (23-25) gauge, hollow needle is inserted into the mass for sampling of cells. • Fine needle aspiration biopsies are very safe minor surgical procedures. Often a major surgical biopsy can be avoided by performing a needle aspiration biopsy instead, eliminating the need for hospitalisation.
  • 5.
    Aspiration techniques Suction FNACCapillary method • In this method, the needle is passed into the lesion and negative pressure is applied, usually by virtue of a syringe attached to the needle • Used predominantly, also known as the non aspiration technique • The needle is passed into the lesion and multiple fast jabbing movements in and out of the lesion as well as in different directions are performed.
  • 6.
    Immunohistochemistry Protocol Fixation andprocessing Section cutting Deparafinisation and rehydration Blocking endogenous enzyme Blocking non specific antibody binding
  • 7.
    Antigen retrieval Primary antibody Chromagen Chromagenenhancement Counter staining Mounting
  • 8.
    Fixation The purpose offixation is to preserve tissue so that it is resistant to undergoing further changes, e.g. by the action of tissue enzymes or microorganisms. Fixation of tissues is necessary: a. To adequately preserve cellular components, including soluble and structural proteins. b. To prevent autolysis and displacement of cell constituents, including Ags and enzymes. c. To stabilize cellular materials against deleterious effects of subsequent procedures d. To facilitate conventional staining and immunostaining. However, the effects of fixation, including protein-protein and protein-nucleic acid cross linking and calcium ion bonding, mask or damage epitopes through alteration of the protein 3 dimensional structure. These changes can often be reversed by any of the multiple antigen retrieval methods.
  • 9.
    Prevention of falsepositives Sometimes normal and neoplasticism cells have endogenous enzyme activity such as peroxidase or alkaline phosphatase. This leads to the generation of false results as the chromogen specific as a substrate for the enzyme stains the antigen when associated with a primary or secondary antibody, but also stains the tissue under inspection diffusely due to the presence of endogenous enzymes. To counteract this, endogenous enzymes need to be blocked before addition of the conjugated Ab- chromogen complex. The most frequently used method is pre- incubation of the sections in absolute methanol containing hydrogen peroxide. A. Before blocking endogenous enzyme activity B. After blocking endogenous enzyme activity
  • 10.
    Antigen retrieval methods Antigenretrieval refers to the unmasking of the epitopes which was induced by formalin fixation and leads to the accessibility of the antigen. The exact mechanism by which antigen retrieval works on formalin-fixed tissues is not clear. A variety of pathways may contribute to its success, including the breaking of cross-linkages, the extraction of diffusible blocking proteins, the precipitation of proteins, the hydrolysis of Schiff's bases, calcium chelation, paraffin removal, and the rehydration of tissue, resulting in better penetration of antibody and increased accessibility to antigen The two major ways through which antigen retrieval is carried out are Protease induced antigen retrieval(PIER) Heat induced antigen retrieval (HIER)
  • 11.
    Several heating methodscan be used to achieve the AR results(HIER): Water baths Microwave ovens Pressure cookers Steamers Antigen retrieval methods
  • 12.
    Antibodies used inIHC assay Polyclonal antibodies Monoclonal antibod 1. Purified immunogen is injected in mice 2. B lymphocytes are harvested f 3. B lymphocytes who have a limited lifespan are fused with ever dividing non senescent myeloma cells to produce a hybridoma The hybridomas having the desired specificity is then selected. The hybrid cell produced is a immortal cell that produces Igs specific for a single epitope.(monoclonal antibodies) Polyclonal antibodies are produced in multiple animal species, particularly rabbit, horse, goat and chicken. Polyclonal Abs have a higher affinity and wide reactivity but lower specificity when compared with monoclonal Abs. They are produced by immunizing an animal with a purified specific molecule (immunogen) bearing the antigen of interest. The animal will mount a humoral response to the immunogen and the antibodies so produced can be harvested. It is likely that the animal will produce multiple clones of plasma cells and hence polyclonal Abs are obtained.
  • 13.
    Labels In immunohistochemistry, manylabels can be used for visualization of an antigen under light or dark microscopy when conjugated with primary or secondary antibodies. Enzyme labels Most commonly used labels in immunohistochemistry due to their small size and prevention of hinderance in binding of Abs to the adjacent sites. The following are the major enzyme labels used in IHC: • Horseradish peroxidase • Glucose oxidase • Alkaline phosphatase • Beta D-galactosidase
  • 14.
    Fluorescent labels More commonlyused in frozen sections. Fluorophore linked antibodies emit a specific colour when excited by correct wavelengths of light. The benefit of using fluorophores is that they provide an easy method for performing double- labelling experiments where several antibodies towards multiple targets are assayed in the same sample. The secondary antibodies need to be targeted towards different primary antibodies and also coupled to different fluorophores. The different secondary antibodies are then observed separately by exciting them sequentially with different wavelengths. These different excitation results are saved as separate images or colour channels and may later be overlaid to infer protein co-localizations. The various fluorochromes commonly used are: • Fluoroscein thiocynate(FITC) • TRITC(rhodamine) • Texas red • R-phytoerythrin(PE)
  • 15.
    Direct Labelling Secondary labelling •There is only one primary antibody that is attached to the antigenic epitope which could be cytoplasmic, membranous or nuclear. • Immunohistochemical staining methods include use of fluorophore-labeled (immunofluorescence) and enzyme-labeled (immunoperoxidase) antibodies to identify proteins and other molecules in cells • In this method, the primary antibody devoid of any fluorochrome or immunoperoxidase activity binds to the epitope of a protein. • A secondary antibody binds to an epitope on the initial primary antibody and has associated with it some labelling activity. This is also referred to as the indirect method of histochemical labelling.
  • 18.
    Procedure at SMIH •Deparafinization of tissue sections taken on polylysine coated slides • Quenching endogenous peroxidase • Antigen retrieval • Serum incubation • Binding of primary antibody • Binding with enzyme labelled secondary antibody • Addition of chromogen substrate DAB • Counterstain, dehydrate coverslipping • Interpretation of pattern of staining and integration of IHC in correct clinical setting
  • 19.
    Application of IHCin diagnostics and theranostics. • IHC is a major tool in the armentarium of a pathologist to confirm or differentiate between tumors • Certain differentiation markers present in the cytoplasm, nucleus or the cell membrane serve as epitopes for antibody labelling. These markers are localised in certain cell lines such as epithelial, mesenchymal, hematopoetic, neuroendocrine, melanocytes to name a few. It is exciting to see that these markers can serve as strong diagnostic tools and panels for differentiating between different tumour phenotype.
  • 20.
    Markers of differentiation 1.Cytokeratins • Cytokeratins are the the most important markers used for the diagnosis of epithelial neoplasms. • Cytokeratins are intermediate filament proteins building an intracytoplasmic network between the nucleus and cell membrane of epithelial cells • Cytokeratins are a complex family composed of more than 20 isotypes and divided into two groups which usually heterodimerize with each other: • Type I(acidic group) including cytokeratins 9-20 • Type II(basic group) including cytokeratins 1-8 Keratins are also divided into high molecular weight keratins(HMWK) and low molecular weight keratins(LMWK)
  • 21.
  • 22.
    CK8/18= simple onelayered non polar epithelial cells Gastrointestinal epithelium additionally expresses CK19 Goblet cells and mature enterocytes: CK20 Biliary,pancreatic ducts, renal collecting tubules: CK7(and transitional epithelium) Basal layer: CK5/14 Intermediate and superficial layers: 1. Non cornified: 4/13 2. Cornified: 1/10 Transitional epithelium- additional CK20 expression along with 8,18,19,7 Mesothelium- CK8,18,19,7(simple epithelia) and stratified epithelial CK5,14 1) HMWK- expressed in squamous cell carcinomas 2) LMWK- expressed in glandular epithelium and visceral parenchyma Simple epithelium Stratified epithelium
  • 25.
    2. Epithelial membraneantigen: LMWK equivalent(marker of glandular epithelium) 3. Carcinoembryonic antigen: marker of glandular epithelium 4. p63: HMWK equivalent: squamous and urothelial epithelium 5. Vimentin: vimentin is a 57kDa protein, a member of the Type III family of intermediate filaments, expressed in all mesenchymal cells forming an important part of the cytoskeleton of these cells. 6. S100 protein: structurally similar to calmodulin however differ from it in terms of cell specific expression pattern. S100 proteins are involved in regulation of protein phosphorylation, transcription factors, Ca++ homeostasis, the dynamics of cytoskeleton constituents, cell growth and differentiation. It can be found in 100% of melanomas and schwannomas. 7. CD45/leukocyte common antigen: family of high molecular mass integral membrane glycoprotein molecules expressed on all hematopoietic cells except mature red cells and their immediate progenitors, megakaryocytes, and platelets. Specific marker for lymphatic and hemopoetic tumours.
  • 27.
    Carcinoma Sarcoma MelanomaLymphoma Keratins + - - - S100 -/+ - + - LCA - - - + Vimentin - + + + Diagnosis of Tumours based on IHC
  • 28.
    Further reading 1. Rubin’spathology 2. Immunohistochemistry in tumour diagnostics- Tuffaha-Guski-Kristiansen